The Yongsam Lee Sells 10,000 Shares of Masimo Corp. (MASI) Stock

The Yongsam Lee Sells 10,000 Shares of Masimo Corp. (MASI) Stock

Masimo Corp. (NASDAQ:MASI) EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction dated Friday, January 13th. The shares were sold at an average price of $72.00, for a total transaction of $720,000.00. Following the completion of the transaction, the executive vice president now owns 79,000 shares in the company, valued at approximately $5,688,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Yongsam Lee also recently made the following trade(s):

Shares of Masimo Corp. (NASDAQ:MASI) opened at 71.79 on Friday. Masimo Corp. has a 52 week low of $33.03 and a 52 week high of $72.50. The stock’s 50 day moving average is $67.00 and its 200-day moving average is $59.92. The company has a market cap of $3.57 billion, a price-to-earnings ratio of 34.66 and a beta of 1.02.

Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, November 2nd. The company reported $0.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.10. Masimo Corp. had a net margin of 16.31% and a return on equity of 29.42%. The business earned $167.60 million during the quarter, compared to analyst estimates of $165.51 million. During the same quarter last year, the business earned $0.36 earnings per share. Masimo Corp.’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, equities analysts anticipate that Masimo Corp. will post $2.14 earnings per share for the current year.

Institutional investors have recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. raised its position in Masimo Corp. by 2.1% in the third quarter. Ameriprise Financial Inc. now owns 351,308 shares of the company’s stock valued at $20,900,000 after buying an additional 7,244 shares during the period. JPMorgan Chase & Co. raised its position in Masimo Corp. by 158.6% in the third quarter. JPMorgan Chase & Co. now owns 341,639 shares of the company’s stock valued at $20,325,000 after buying an additional 209,509 shares during the period. Rothschild Asset Management Inc. raised its position in Masimo Corp. by 4.6% in the third quarter. Rothschild Asset Management Inc. now owns 287,595 shares of the company’s stock valued at $17,109,000 after buying an additional 12,732 shares during the period. BlackRock Fund Advisors raised its position in Masimo Corp. by 6.2% in the third quarter. BlackRock Fund Advisors now owns 3,082,642 shares of the company’s stock valued at $183,386,000 after buying an additional 180,127 shares during the period. Finally, ClariVest Asset Management LLC raised its position in Masimo Corp. by 15.6% in the third quarter. ClariVest Asset Management LLC now owns 71,982 shares of the company’s stock valued at $4,283,000 after buying an additional 9,707 shares during the period. Institutional investors and hedge funds own 82.28% of the company’s stock.

MASI has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Masimo Corp. from a “buy” rating to a “hold” rating in a research report on Monday, January 9th. Wedbush reaffirmed an “outperform” rating and set a $75.00 target price on shares of Masimo Corp. in a research note on Monday, November 14th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $55.00.

About Masimo Corp.

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

Related posts

Leave a Comment